Table 4.
Case n°/Reference | Year ** | Age | Sex | Species | Cause of ESRD | Therapy Regimen | Therapy Duration | Outcome | Catheter Removal |
---|---|---|---|---|---|---|---|---|---|
1 [43] | 1981 | 70 | M | N. asteroides | CIN | Ceph, Sulf | 6 weeks | survived | No |
2 [44] | 1990 | 60 | M | NR | PCKD | Ofl, Tob, Ceph, Van, Azt, TMP/SMX | 8 weeks | survived | No |
3 [45] | 1990 | 58 | F | N. asteroides | NR | Ceft, Net, Van, TMP/SMX | NR | survived | Yes |
4 [46] | 1993 | 38 | M | N. asteroides | SLE | Ceph, TMP/SMX | 4 weeks | died | No |
5 [47] | 1994 | 80 | M | N. nova | NR | TMP/SMX | 3 weeks | survived | Yes |
6 [48] | 2001 | 32 | M | N. nova | Type 1 DM | TMP/SMX, Imi | 4 months | survived | Yes |
7 [49] | 2003 | 68 | F | N. nova | Unknown | Cefa, Net, Ceft, Amk, Imi, TMP/SMX, Cef | 2 weeks | died | No |
8 [50] | 2005 | 35 | M | N. asteroides | CBUS | Van, Ceft, TMP/SMX, Amk, Cefu | 19 weeks | survived | No |
9 [51] | 2008 | 75 | M | NR | Type 2 DM | Van, TMP/SMX | 11 weeks | survived | Yes |
10 [8] | 2008 | 66 | M | N. asteroides | Type 2 DM | Cefa, Gen TMP/SMX | 12 months | survived | Yes |
11 [52] | 2011 | 57 | M | N. asteroides | Type 2 DM | Van, Ceft, TMP/SMX, Cef, Cip | 2 weeks | died | Yes |
12 [53] | 2016 | 13 | F | N. asteroides | DGS | Van, Cip, Ceft, Line | 8 months | survived | Yes |
Abbreviations: Azt = aztreonam; Cef = ceftriaxone; Cefa = cefazolin; Ceft = ceftazidime; Cefu = cefuroxime; Ceph = cephalotin; Cip = ciprofloxacin; CIN = chronic interstitial nephritis; CBUS = congenital bilateral ureteral stenosis; DGS= diffuse global sclerosis; DM = diabetes mellitus; ESRD = end-stage renal disease; Gen = gentamycin; Imi = imipenem; Line = linezolid; Net = netilmycin; NR = not reported; Ofl = ofloxacin; PCKD = polycystic kidney disease; SLE = systemic lupus erythematous; Sulf = sulfisoxazole; TMP/SMX = trimethoprim-sulfamethoxazole; Tob = tobramycin; Van = vancomycin; ** Year of pulication.